Crystalline nephropathies

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 7, 2012, Pages 713-720

  Herlitz, Leal C ^a   D'Agati, Vivette D ^a   Markowitz, Glen S ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE;

HUMAN; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; REVIEW;

CALCIUM OXALATE; HUMANS; KIDNEY; KIDNEY DISEASES;

EID: 84864254542     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0565-RA     Document Type: Review

References (47)

1. Markowitz GS. Dysproteinemia and the kidney. Adv Anat Pathol. 2004; 11(1):49-63.
2. Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J AmSoc Nephrol. 2001;12(7):1482-1492. (Pubitemid 32666331)
3. Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D'Agati VD. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70(12):2148-2151. (Pubitemid 44871379)
4. Kapur U, Barton K, Fresco R, Leehey DJ, Picken MM. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch Pathol Lab Med. 2007;131(9):1368-1372. (Pubitemid 47427590)
5. Maldonado JE, Velosa JA, Kyle RA, Wagoner RD, Holley KE, Salassa RM. Fanconi syndrome in adults: a manifestation of a latent form of myeloma. Am J Med. 1975;58(3):354-364.
6. Messiaen T, Deret S, Mougenot B, et al. Adult Fanconi syndrome secondary to light chain gammopathy: clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79(3):135-154. (Pubitemid 30327529)
7. Rao DS, Parfitt AM, Villanueva AR, Dorman PJ, Kleerekoper M. Hypophosphatemic osteomalacia and adult Fanconi syndrome due to lightchain nephropathy: another form of oncogenous osteomalacia. Am J Med. 1987; 82(2):333-338.
8. Thorner PS, Bédard YC, Fernandes BJ. Lambda-light-chain nephropathy with Fanconi's syndrome. Arch Pathol Lab Med. 1983;107(12):654-657.
9. Herlitz LC, Roglieri J, Resta R, Bhagat G, Markowitz GS. Light chain proximal tubulopathy. Kidney Int. 2009;76(7):792-797.
10. Aucouturier P, Bauwens M, Khamlichi AA, et al. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J Immunol. 1993;150(8, pt 1):3561-3568. (Pubitemid 23129737)
11. Leboulleux M, Lelongt B, Mougenot B, et al. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney Int. 1995; 48(1):72-79.
12. Sirac C, Bridoux F, Carrion C, et al. Role of the monoclonal k chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood. 2006;108(2):536-543. (Pubitemid 44061353)
13. Stokes MB, Aronoff B, Siegel D, D'Agati VD. Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis. Kidney Int. 2006;70(3): 597-602. (Pubitemid 44141589)
14. Farooq U, Bayerl MG, Abendroth CS, Verma N, Talamo G. Renal crystal storing histiocytosis in a patient with multiple myeloma. Ann Hematol. 2009; 88(8):807-809.
15. El Hamel C, Thierry A, Trouillas P, et al. Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant. 2010;25(9):2982-2990.
16. Lebeau A, Zeindl-Eberhart E, Müller EC, et al. Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature. Blood. 2002; 100(5):1817-1827. (Pubitemid 34925162)
17. Yarlagadda SG, Perazella MA. Drug-induced crystal nephropathy: an update. Expert Opin Drug Saf. 2008;7(2):147-158. (Pubitemid 351447697)
18. Molina JM, Belenfant X, Doco-Lecompte T, Idatte JM, Modai J. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. AIDS. 1991;5(5):587-589.
19. Simon DI, Brosius FC III, Rothstein DM. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1990;150(11):2379-2384. (Pubitemid 20365248)
20. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovir-induced renal failure: clinical course and histology. Am J Med. 1988;84(6):1067-1071.
21. Tashima KT, Horowitz JD, Rosen S. Indinavir nephropathy. N Engl J Med. 1997;336(2):138-140.
22. Reilly RF, Tray K, Perazella MA. Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors. Am J Kidney Dis. 2001; 38(4):E23.
23. Kopp J, Miller K, Mican J, et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med. 1997;127(2):119-125. (Pubitemid 27337395)
24. Proia AD, Brinn NT. Identification of calcium oxalate crystals using alizarin red S stain. Arch Pathol Lab Med. 1985;109(2):186-189. (Pubitemid 15166074)
25. Beall DP, Henslee HB, Webb HR, Scofield RH. Milk-alkali syndrome: a historical review and description of the modern version of the syndrome. Am J Med Sci. 2006;331(5):233-242. (Pubitemid 43804600)
26. Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90(11):6316-6322. (Pubitemid 41606563)
27. Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V. Dent's disease: clinical features and molecular basis. Pediatr Nephrol. 2011;26(5):693-704.
28. Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol. 2005;16(11):3389-3396. (Pubitemid 46179342)
29. Markowitz GS, Nasr SH, Klein P, et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol. 2004;35(6):675-684. (Pubitemid 38881077)
30. Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int. 2009;76(10):1027-1034.
31. Dobbins JW, Binder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med. 1977;296(6):298-301. (Pubitemid 8047241)
32. Dobbins JW, Binder HJ. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology. 1976;70(6):1096-1100.
33. Mole DR, Tomson CR, Mortensen N, Winearls CG. Renal complications of jejuno-ileal bypass for obesity. QJM. 2001;94(2):69-77. (Pubitemid 32175532)
34. Nasr SH, D'Agati VD, Said SM, et al. Oxalate nephropathy complicating roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3(6):1676-1683.
35. Singh A, Sarkar SR, Gaber LW, Perazella MA. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Am J Kidney Dis. 2007; 49(1):153-157. (Pubitemid 44932193)
36. Haggerty RJ. Toxic hazards; deaths from permanent antifreeze ingestion. N Engl J Med. 1959;261(25):1296-1297.
37. Poldelski V, Johnson A, Wright S, Rosa VD, Zager RA. Ethylene glycolmediated tubular injury: identification of critical metabolites and injury pathways. Am J Kidney Dis. 2001;38(2):339-348. (Pubitemid 32729279)
38. Jacobsen D, Hewlett TP, Webb R, Brown ST, Ordinario AT, McMartin KE. Ethylene glycol intoxication: evaluation of kinetics and crystalluria. Am J Med. 1988;84(1):145-152.
39. Lamarche J, Nair R, Peguero A, Courville C. Vitamin C-induced oxalate nephropathy [published online ahead of print March 16, 2011]. Int J Nephrol. doi:10.4061/2011/146927
40. Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P. Primary hyperoxaluria [published online ahead of print June 16, 2011]. Int J Nephrol. doi:10.4061/2011/864580.
41. Kjellstrand CM, Cambell DC II, von Hartitzsch B, Buselmeier TJ. Hyperuricemic acute renal failure. Arch Intern Med. 1974;133(3):349-359.
42. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med. 2004;116(8):546-554. (Pubitemid 38452647)
43. Finn LS, Bernstein J. Renal disease caused by familial metabolic and hematologic diseases. In: Jennette J, Olson J, Schwartz M, Silva F, eds. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:1230-1232.
44. Devonald MA, Karet FE. Renal epithelial traffic jams and one-way streets. J Am Soc Nephrol. 2004;15(6):1370-1381. (Pubitemid 38679662)
45. Seshan S, D'Agati V, Appel G, Churg J. Renal Disease: Classification and Atlas of Tubulo-interstitial and Vascular Diseases, Baltimore, MD; Williams & Wilkins; 1998:192-195.
46. Chandra M, Stokes MB, Kaskel F. Multinucleated podocytes: a diagnostic clue to cystinosis. Kidney Int. 2010;78(10):1052.
47. Nasr SH, Sethi S, Cornell LD, et al. Crystalline nephropathy due to 2,8- dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant. 2010;25(6):1909-1915.